Your Bag

Your bag is empty.

Descriptive text for the image
undefined thumbnail image

Cytocare 532

£139.99

Sorry, this item is currently out of stock

Cytocare 532

Professional Use Only

Product Overview

Cytocare 532 is an advanced bio-revitalising mesotherapy injectable formulated to deeply hydrate, rejuvenate, and improve overall skin quality. It combines a high concentration of non-crosslinked hyaluronic acid (32 mg per 5 ml) with a patented CT50 Rejuvenating Complex — a blend of essential vitamins, amino acids, antioxidants, and trace elements designed to support cellular regeneration, optimise hydration, and help reduce the appearance of fine lines and signs of ageing.

Unlike volumising fillers, Cytocare 532 enhances the skin’s texture, elasticity, and radiance, making it ideal for revitalisation and maintenance treatments rather than structural tissue augmentation.


What’s Included in Each Pack

  • 10 × 5 ml sterile vials of Cytocare 532 injectable solution
    (Also available in 5 × 5 ml and single-vial formats)
    • High-concentration hyaluronic acid (32 mg/5 ml)
    • CT50 Rejuvenating Complex (vitamins, amino acids, trace elements)

All vials are supplied in sealed sterile packaging to preserve product safety and integrity.


Intended Treatment Areas

Cytocare 532 is designed for skin revitalisation in areas where hydration, luminosity, and fine line improvement are desired, including:

  • Face

  • Neck

  • Décolletage

  • Backs of hands

  • Scalp (when indicated)

The solution is administered into the superficial to mid dermis using micro-injection techniques or devices such as meso-rollers or microneedling pens, targeting areas showing signs of dehydration, dullness, or early ageing.


Key Benefits

  • Intense hydration and water retention via high-concentration hyaluronic acid

  • Boosts fibroblast activity to support natural collagen and elastin production

  • Improved skin texture, elasticity, and radiance

  • Helps soften fine lines and early signs of ageing

  • Antioxidant support via vitamins and trace elements

  • Suitable as part of preventive or corrective mesotherapy programs


Expected Longevity

Improvements in skin hydration, texture, and glow are often visible soon after treatment. Optimal results typically emerge over subsequent weeks as cellular regeneration and dermal rejuvenation progress.

Treatment protocols commonly consist of multiple sessions spaced at regular intervals (e.g., every 3 weeks), with maintenance treatments recommended to support ongoing skin quality enhancement.


Regulatory & Compliance Information

Product Origin & Certification

Cytocare 532 is manufactured by Laboratoire Revitacare in France and is distributed as a CE-marked medical device suitable for professional mesotherapy and skin revitalisation use.

This product is intended for use by qualified medical or aesthetic professionals only. Practitioners must check and comply with all local regulatory requirements before use.


Returns & Refunds

Refunds are only issued for:

  • Manufacturing defects

  • Product damage upon receipt

Your statutory rights remain unaffected. Refunds will not be provided for issues arising from incomplete qualification documentation or non-compliance with ordering policies.


Important Professional Notice

🚫 This product must only be purchased, stored, and administered by qualified and appropriately trained professionals.

Cytocare 532 requires expertise in mesotherapy or aesthetic injection techniques and a thorough understanding of facial anatomy and skin physiology.


Liability Disclaimer

Inked Crown assumes no responsibility for:

  • Improper administration

  • Incorrect injection technique

  • Complications arising from misuse

  • Failure to follow manufacturer protocols

  • Improper storage or handling of the product

Practitioners must:

  • Read and follow all official product documentation

  • Maintain clinical hygiene and safety standards

  • Use appropriate injection techniques

  • Provide thorough consultation and aftercare advice to clients

Safe use and professional compliance remain the responsibility of the administering practitioner.